Evidence map›Paper›PMID 30929335›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2019

[Studies on the role of chromobox protein homolog 2 in the inhibition of progression of hepatoma].

J Li, Z X Guo, J A Chen, C Xue, L L Sun, Z G Ren, A Li, G Y Cui, Z J Yu

Open access · greenAbstract read
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

J LiInfectious Diseases Department, the First Affliated Hospital of Zhengzhou University, Zhengzhou 450052, China; Precision Medicine Center, the First Affliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Z X GuoInfectious Diseases Department, the First Affliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
J A ChenInfectious Diseases Department, the First Affliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
C XueInfectious Diseases Department, the First Affliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
L L SunInfectious Diseases Department, the First Affliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Z G RenInfectious Diseases Department, the First Affliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
A LiPrecision Medicine Center, the First Affliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
G Y CuiInfectious Diseases Department, the First Affliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Z J YuInfectious Diseases Department, the First Affliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
First Affiliated Hospital of Zhengzhou University · CN

Funding

Henan Province Medical Academic Technology Leaders Training Abroad Program 2017031Key Scientific Research Project of Henan Higher Education Institutions of China 18A320038the Medical Science and Technology research project of Henan province 201702001The National Natural Science Foundation of China 81702927
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsAdultCell ProliferationDown-RegulationGene Expression Regulation, NeoplasticHep G2 CellsHumansCarcinoma, hepatocellularCBX2Gene expressionPrognosis

Identifiers

PMID30929335
PMCPMC12814008
OpenAlexW2971065364

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.